Physician

Ramesh Vedula, MD

According to 2025 Medicare claims, Ramesh Vedula, MD (NPI: 1881630895) practices radiation oncology in the Sierra Vista-Douglas, AZ market, with the plurality of this provider's patient population coming from Cochise, AZ. This provider's primary affiliated billing organization is COCHISE ONCOLOGY LLC (NPI: 1013954858; TIN: 202022023) and primary practice location at 85635-2436. Vedula is affiliated with the ABC Network (ACO ID: A5554), participating under the MSSP model.

Vedula's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 221 traditional Medicare patients, billed 4,570 HCPCS/CPT codes, and received $869,287 in Medicare payments. The top billing code was 77280 (Obtaining data needed to develop the optimal radiation treatment, 1 treatment area). Part D data shows 294 prescription claims across 96 beneficiaries totaling $296,550 in drug costs, led by Anastrozole (Anastrozole). Open Payments data shows 53 records totaling $1,022. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $369,744 to $869,287. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $18,325 and ending at $296,550. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	169	2,242	$369,744
2016	108	1,003	$95,838
2017	112	1,075	$94,539
2018	114	1,033	$92,241
2019	127	1,120	$96,104
2020	N/R	N/R	N/R
2021	136	3,745	$789,792
2022	179	5,273	$1,070,479
2023	185	4,074	$769,991
2024	221	4,570	$869,287

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	29	43	$18,325
2016	34	55	$1,787
2017	39	79	$3,321
2018	42	106	$4,813
2019	29	58	$1,414
2020	N/R	N/R	N/R
2021	51	128	$19,451
2022	75	171	$56,565
2023	73	203	$8,927
2024	96	294	$296,550

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77280	Obtaining data needed to develop the optimal radiation treatment, 1 treatment area	81	337	$204
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	74	74	$159
77263	Complex radiation therapy planning	60	71	$128
77334	Design and construction of complex radiation treatment device	62	68	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	144	256	$87

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Anastrozole	Anastrozole	40	3,240	$874
Dexamethasone	Dexamethasone	20	250	$344
Levothyroxine Sodium	Levothyroxine Sodium	19	1,650	$256
Oxycodone Hcl	Oxycodone Hcl	12	237	$161
Cephalexin	Cephalexin	15	83	$152

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$1,022	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ramesh Vedula, MD?

Tedicare shows public-source Medicare data for Ramesh Vedula, MD (NPI 1881630895), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ramesh Vedula, MD have ACO affiliation data?

Ramesh Vedula, MD is shown with ACO affiliation data for ABC Network (MSSP, ACO ID A5554).

What billing organization is linked to Ramesh Vedula, MD?

Ramesh Vedula, MD is linked to COCHISE ONCOLOGY LLC (billing NPI 1013954858) in the available physician profile data.

Does Ramesh Vedula, MD have Open Payments data?

Ramesh Vedula, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.